Table 1 Clinical event incidence before and during shortage.
From: Consequences of a global enzyme shortage of agalsidase beta in adult Dutch Fabry patients
| Â | Before shortage | During shortage | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Â | CE n | Mean follow-up | Mean CE incidence | Median CE incidence | Range | CE n | Mean follow-up | Mean CE incidence | Median CE incidence | Range | P |
Male (n = 17) | 20 | 5.3 | 0.23 | 0.17 | 0-1 | 3 | 1.32 | 0.14 | 0 | 0-1.62 | 0.25 |
Female (n = 18) | 8 | 3.9 | 0.07 | 0 | 0-0.68 | 4 | 1.32 | 0.16 | 0 | 0-0.83 | 0.40 |
Total | 28 | 4.6 | 0.15 | 0 | 0-1 | 7 | 1.32 | 0.15 | 0 | 0-1.62 | 0.68 |